Facultad de Psicología, Universidad Nacional de Educación a Distancia, 28040 Madrid, Spain.
Instituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas, 28029 Madrid, Spain.
Horm Behav. 2020 Sep;125:104839. doi: 10.1016/j.yhbeh.2020.104839. Epub 2020 Aug 22.
Body feminization, as part of gender affirmation process of transgender women, decreases the volume of their cortical and subcortical brain structures. In this work, we implement a rat model of adult male feminization which reproduces the results in the human brain and allows for the longitudinal investigation of the underlying structural and metabolic determinants in the brain of adult male rats undergoing feminization treatments. Structural MRI and Diffusion Tensor Imaging (DTI) were used to non-invasively monitor in vivo cortical brain volume and white matter microstructure over 30 days in adult male rats receiving estradiol (E), estradiol plus cyproterone acetate (CA), an androgen receptor blocker and antigonadotropic agent (E + CA), or vehicle (control). Ex vivo cerebral metabolic profiles were assessed by H High Resolution Magic Angle Spinning NMR (H HRMAS) at the end of the treatments in samples from brain regions dissected after focused microwave fixation (5 kW). We found that; a) Groups receiving E and E + CA showed a generalized bilateral decrease in cortical volume; b) the E + CA and, to a lesser extent, the E groups maintained fractional anisotropy values over the experiment while these values decreased in the control group; c) E treatment produced increases in the relative concentration of brain metabolites, including glutamate and glutamine and d) the glutamine relative concentration and fractional anisotropy were negatively correlated with total cortical volume. These results reveal, for the first time to our knowledge, that the volumetric decreases observed in trans women under cross-sex hormone treatment can be reproduced in a rat model. Estrogens are more potent drivers of brain changes in male rats than anti-androgen treatment.
身体女性化是跨性别女性性别认同过程的一部分,会导致其皮质和皮质下脑结构体积减小。在这项工作中,我们建立了一个成年雄性大鼠女性化模型,该模型复制了人类大脑的结果,并允许对接受女性化治疗的成年雄性大鼠大脑中的潜在结构和代谢决定因素进行纵向研究。结构磁共振成像(MRI)和弥散张量成像(DTI)用于在接受雌二醇(E)、雌二醇加醋酸环丙孕酮(CA)、雄激素受体阻滞剂和抗促性腺激素药物(E+CA)或载体(对照)治疗的成年雄性大鼠中,非侵入性地监测皮质脑体积和白质微观结构的变化。在治疗结束时,通过高分辨率魔角旋转核磁共振(HRMAS)对离体脑代谢谱进行评估,并在聚焦微波固定(5kW)后从大脑区域样本中进行。我们发现:a)接受 E 和 E+CA 的组表现出双侧皮质体积普遍减少;b)E+CA 组和在较小程度上的 E 组在实验过程中保持各向异性分数值,而对照组的这些值下降;c)E 治疗会增加脑代谢物的相对浓度,包括谷氨酸和谷氨酰胺;d)谷氨酰胺相对浓度与各向异性分数呈负相关,与总皮质体积呈负相关。这些结果首次表明,在接受跨性别激素治疗的跨性别女性中观察到的体积减少可以在大鼠模型中重现。雌激素比抗雄激素治疗更能促进雄性大鼠的大脑变化。